BIEL OTC
Bioelectronics Corporation
1W: +0.0%
1M: +0.0%
3M: +20.0%
YTD: -25.0%
1Y: +100.0%
3Y: -25.0%
5Y: -84.2%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±50.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$164K
+51.1% ▲
Capital Expenditures
$3
+0.0% ▲
Free Cash Flow
-$164K
+51.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3K
+107.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$290K | -$227K | -$723K | -$931K |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $161K | $6K | $0 | $0 | $0 |
| Change in Working Capital | $216K | -$279K | -$65K | -$111K | $229K |
| Other Non-Cash Items | $255K | $242K | -$187K | $498K | $538K |
| Operating Cash Flow | -$528K | -$320K | -$479K | -$336K | -$164K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $591K | $212K | $523K | $296K | $167K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $591K | $212K | $523K | $296K | $167K |
| Net Change in Cash | $63K | -$109K | $44K | -$40K | $3K |
| Cash End of Period | $110K | $925 | $45K | $5K | $8K |
| Free Cash Flow | -$528K | -$320K | -$479K | -$336K | -$164K |